Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®

Completed · Phase 4

Conditions studied: Glaucoma, Ocular Hypertension

In brief

Comparing Safety and Efficacy of Combigan® and Lumigan® with Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated with Xalatan®.

Key facts

Study ID

NCT01170884

Run by

Allergan

People needed

121

Starts

2009-12-01

Expected to finish

2010-09-01

Last updated by the study team

2019-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with glaucoma or ocular hypertension.
• Visual Acuity 20/100 or better in both eyes

You may not qualify if…

• Any active ocular disease
• History of any intraocular surgery or glaucoma laser surgery within 3 months
• Contraindication to pupil dilation
• Use of topical, periorbital, intravitreal, or systemic steroid within 3 months

Where it is running

• Study site — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.